Free fatty acid metabolism in human obesity

Journal of Lipid Research

Volumn 47, Issue 8, 2006, Pages 1643-1650

  Koutsari, Christina ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Fat distribution; Regional lipolysis; Resting energy expenditure; Sex; Subcutaneous adipose tissue; Visceral fat

Indexed keywords

FATTY ACID; STABLE ISOTOPE; TRACER;

BODY FAT DISTRIBUTION; CORRELATION ANALYSIS; DYSLIPIDEMIA; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; METABOLIC CLEARANCE RATE; OBESITY; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; SUBCUTANEOUS FAT; ADIPOSE TISSUE; FEMALE; LIPID METABOLISM; MALE; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LIPID METABOLISM; MALE; OBESITY;

EID: 33745784213     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R600011-JLR200     Document Type: Review

References (74)

1. Haslam, D. W., and W. P. James. 2005. Obesity. Lancet. 366: 1197-1209.
2. Hedley, A. A., C. L. Ogden, C. L. Johnson, M. D. Carroll, L. R. Curtin, and K. M. Flegal. 2004. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. J. Am. Med. Assoc. 291: 2847-2850.
3. Green Paper. Promoting Healthy Diets and Physical Activity: A European Dimension for the Prevention of Overweight, Obesity and Chronic Diseases. Commission of the European Communities, Brussels, Belgium. December 8, 2005.
4. Kim, S., and B. M. Popkin. 2006. Understanding the epidemiology of overweight and obesity - a real global public health concern. Int. J. Epidemiol. 35: 60-67 (discussion 81-82).
5. Kelley, D. E., M. Mokan, J. A. Simoneau, and L. J. Mandarino. 1993. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92: 91-98.
6. Rebrin, K., G. M. Steil, S. D. Mittelman, and R. N. Bergman. 1996. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98: 741-749.
7. Steinberg, H. O., M. Tarshoby, R. Monestel, G. Hook, J. Cronin, A. Johnson, B. Bayazeed, and A. D. Baron. 1997. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J. Clin. Invest. 100: 1230-1239.
8. Zhou, Y. P., and V. E. Grill. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93: 870-876.
9. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. 1995. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166.
10. Canoy, D., R. Luben, A. Welch, S. Bingham, N. Wareham, N. Day, and K. T. Khaw. 2004. Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J. Hypertens. 22: 2067-2074.
11. Heitmann, B. L., P. Frederiksen, and L. Lissner. 2004. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes. Res. 12: 482-487.
12. Snijder, M. B., J. M. Dekker, M. Visser, L. M. Bouter, C. D. Stehouwer, J. S. Yudkin, R. J. Heine, G. Nijpels, and J. C. Seidell. 2004. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care. 27: 372-377.
13. Van Pelt, R. E., C. M. Jankowski, W. S. Gozansky, R. S. Schwartz, and W. M. Kohrt. 2005. Lower-body adiposity and metabolic protection in postmenopausal women. J. Clin. Endocrinol. Metab. 90: 4573-4578.
14. Heilbronn, L., S. R. Smith, and E. Ravussin. 2004. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 28 (Suppl. 4): 12-21.
15. Sonnenberg, G. E., G. R. Krakower, and A. H. Kissebah. 2004. A novel pathway to the manifestations of metabolic syndrome. Obes. Res. 12: 180-186.
16. Dandona, P., A. Aljada, and A. Bandyopadhyay. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25: 4-7.
17. Frayn, K. N. 2005. Obesity and metabolic disease: is adipose tissue the culprit? Proc. Nutr. Soc. 64: 7-13.
18. Ruan, H., and H. F. Lodish. 2004. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr. Opin. Lipidol. 15: 297-302.
19. Bjorntorp, P., H. Bergman, E. Varnauskas, and B. Lindholm. 1969. Lipid mobilization in relation to body composition in man. Metabolism. 18: 840-851.
20. Wolfe, R. R., S. Klein, F. Carraro, and J. M. Weber. 1990. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am. J. Physiol. 258: E382-E389.
21. Campbell, P. J., M. G. Carlson, J. O. Hill, and N. Nurjhan. 1992. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am. J. Physiol. 263: E1063-E1069.
22. Bougneres, P., C. L. Stunff, C. Pecqueur, E. Pinglier, P. Adnot, and D. Ricquier. 1997. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J. Clin. Invest. 99: 2568-2573.
23. van der Valk, M., G. Allick, G. J. Weverling, J. A. Romijn, M. T. Ackermans, J. M. Lange, B. L. van Eck-Smit, C. van Kuijk, E. Endert, H. P. Sauerwein, et al. 2004. Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients. J. Clin. Endocrinol. Metab. 89: 3554-3560.
24. Jacobs, K. A., G. A. Casazza, S. H. Suh, M. A. Horning, and G. A. Brooks. 2005. Fatty acid reesterification but not oxidation is increased by oral contraceptive use in women. J. Appl. Physiol. 98: 1720-1731.
25. Jensen, M. D. 1999. Regional glycerol and free fatty acid metabolism before and after meal ingestion. Am. J. Physiol. 276: E863-E869.
26. Van Hall, G., J. Bulow, M. Sacchetti, N. Al Mulla, D. Lyngso, and L. Simonsen. 2002. Regional fat metabolism in human splanchnic and adipose tissues: the effect of exercise. J. Physiol. 543: 1033-1046.
27. Issekutz, B., Jr., W. M. Bortz, H. I. Miller, and P. Paul. 1967. Turnover rate of plasma FFA in humans and in dogs. Metabolism. 16: 1001-1009.
28. Nestel, P. J., and H. M. Whyte. 1968. Plasma free fatty acid and triglyceride turnover in obesity. Metabolism. 17: 1122-1128.
29. Eaton, R. P., M. Berman, and D. Steinberg. 1969. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J. Clin. Invest. 48: 1560-1579.
30. Lillioja, S., J. Foley, C. Bogardus, D. Mott, and B. V. Howard. 1986. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons. Metabolism. 35: 505-514.
31. Miles, J. M., M. G. Ellman, K. L. McClean, and M. D. Jensen. 1987. Validation of a new method for determination of free fatty acid turnover. Am. J. Physiol. 252: E431-E438.
32. Jensen, M. D., P. J. Rogers, M. G. Ellman, and J. M. Miles. 1988. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am. J. Physiol. 254: E562-E565.
33. Jensen, M. D., V. Heiling, and J. M. Miles. 1990. Measurement of non-steady-state free fatty acid turnover. Am. J. Physiol. 258: E103-E108.
34. Boden, G., X. Chen, R. A. Desantis, and Z. Kendrick. 1993. Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes. 42: 1588-1593.
35. Martin, W. H., 3rd, G. P. Dalsky, B. F. Hurley, D. E. Matthews, D. M. Bier, J. M. Hagberg, M. A. Rogers, D. S. King, and J. O. Holloszy. 1993. Effect of endurance training on plasma free fatty acid turnover and oxidation during exercise. Am. J. Physiol. 265: E708-E714.
36. Klein, S., E. F. Coyle, and R. R. Wolfe. 1994. Fat metabolism during low-intensity exercise in endurance-trained and untrained men. Am. J. Physiol. 267: E934-E940.
37. Friedlander, A. L., G. A. Casazza, M. A. Horning, T. F. Buddinger, and G. A. Brooks. 1998. Effects of exercise intensity and training on lipid metabolism in young women. Am. J. Physiol. 275: E853-E863.
38. Tchernof, A., R. D. Starling, J. D. Walston, A. R. Shuldiner, R. V. Dvorak, K. Silver, D. E. Matthews, and E. T. Poehlman. 1999. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes. 48: 1425-1428.
39. Zuijdgeest-van Leeuwen, S. D., J. W. van den Berg, J. L. Wattimena, A. van der Gaast, G. R. Swart, J. H. Wilson, and P. C. Dagnelie. 2000. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism. 49: 931-936.
40. Horowitz, J. F., and S. Klein. 2000. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am. J. Physiol. Endocrinol. Metab. 278: E1144-E1152.
41. 13C]palmitate. J. Lipid Res. 38: 1888-1895.
42. Mazess, R. B., H. S. Barden, J. P. Bisek, and J. Hanson. 1990. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am. J. Clin. Nutr. 51: 1106-1112.
43. Jensen, M. D., J. A. Kanaley, J. E. Reed, and P. F. Sheedy. 1995. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am. J. Clin. Nutr. 61: 274-278.
44. Birkenhager, J. C., and T. Tjabbes. 1969. Turnover rate of plasma FFA and rate of esterification of plasma FFA to plasma triglycerides in obese humans before and after weight reduction. Metabolism. 18: 18-32.
45. Campbell, P. J., M. G. Carlson, and N. Nurjhan. 1994. Fat metabolism in human obesity. Am. J. Physiol. 266: E600-E605.
46. Horowitz, J. F., S. W. Coppack, D. Paramore, P. E. Cryer, G. Zhao, and S. Klein. 1999. Effect of short-term fasting on lipid kinetics in lean and obese women. Am. J. Physiol. 276: E278-E284.
47. Mittendorfer, B., D. A. Fields, and S. Klein. 2004. Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am. J. Physiol. Endocrinol. Metab. 286: E354-E362.
48. Bjorntorp, P., H. Bergman, and E. Varnauskas. 1969. Plasma free fatty acid turnover rate in obesity. Acta Med. Scand. 185: 351-356.
49. Jensen, M. D., M. W. Haymond, R. A. Rizza, P. E. Cryer, and J. M. Miles. 1989. Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest. 83: 1168-1173.
50. Martin, M. L., and M. D. Jensen. 1991. Effects of body fat distribution on regional lipolysis in obesity. J. Clin. Invest. 88: 609-613.
51. Tanner, J. M. 1949. Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation. J. Appl. Physiol. 2: 1-15.
52. Nielsen, S., Z. Guo, J. B. Albu, S. Klein, P. C. O'Brien, and M. D. Jensen. 2003. Energy expenditure, sex, and endogenous fuel availability in humans. J. Clin. Invest. 111: 981-988.
53. Jensen, M. D., and C. M. Johnson. 1996. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism. 45: 662-666.
54. Tan, G. D., G. H. Goossens, S. M. Humphreys, H. Vidal, and F. Karpe. 2004. Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans. Obes. Res. 12: 114-118.
55. Bjorntorp, P. 1990. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 10: 493-496.
56. Lebovitz, H. E., and M. A. Banerji. 2005. Point. Visceral adiposity is causally related to insulin resistance. Diabetes Care. 28: 2322-2325.
57. Jensen, M. D., S. Cardin, D. Edgerton, and A. Cherrington. 2003. Splanchnic free fatty acid kinetics. Am. J. Physiol. Endocrinol. Metab. 284: E1140-E1148.
58. Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen. 2004. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113: 1582-1588.
59. Jensen, M. D., K. Ekberg, and B. R. Landau. 2001. Lipid metabolism during fasting. Am. J. Physiol. Endocrinol. Metab. 281: E789-E793.
60. Roust, L. R., and M. D. Jensen. 1993. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes. 42: 1567-1573.
61. Banerji, M. A., N. Faridi, R. Atluri, R. L. Chaiken, and H. E. Lebovitz. 1999. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 84: 137-144.
62. Rendell, M., U. L. Hulthen, C. Tornquist, L. Groop, and I. Mattiasson. 2001. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J. Clin. Endocrinol. Metab. 86: 744-749.
63. Nguyen-Duy, T. B., M. Z. Nichaman, T. S. Church, S. N. Blair, and R. Ross. 2003. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am. J. Physiol. Endocrinol. Metab. 284: E1065-E1071.
64. Guo, Z., D. D. Hensrud, C. M. Johnson, and M. D. Jensen. 1999. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes. 48: 1586-1592.
65. Nguyen, T. T., A. H. Mijares, C. M. Johnson, and M. D. Jensen. 1996. Postprandial leg and splanchnic fatty acid metabolism in nonobese men and women. Am. J. Physiol. 271: E965-E972.
66. Basu, A., R. Basu, P. Shah, A. Vella, R. A. Rizza, and M. D. Jensen. 2001. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 280: E1000-E1006.
67. Abate, N., A. Garg, R. M. Peshock, J. Stray-Gundersen, and S. M. Grundy. 1995. Relationships of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Invest. 96: 88-98.
68. Kelley, D. E., F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster. 2000. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 278: E941-E948.
69. Phillips, D. I., S. Caddy, V. Ilic, B. A. Fielding, K. N. Frayn, A. C. Borthwick, and R. Taylor. 1996. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism. 45: 947-950.
70. Seppala-Lindroos, A., S. Vehkavaara, A. M. Hakkinen, T. Goto, J. Westerbacka, A. Sovijarvi, J. Halavaara, and H. Yki-Jarvinen. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87: 3023-3028.
71. Shadid, S., and M. D. Jensen. 2006. Pioglitazone increases nonesterified fatty acid clearance in upper body obesity. Diabetologia. 49: 149-157.
72. Bajaj, M., S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo. 2005. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes. 54: 3148-3153.
73. Farquhar, J. W., R. C. Gross, R. M. Wagner, and G. M. Reaven. 1965. Validation of an incompletely coupled two-compartment nonrecycling catenary model for turnover of liver and plasma triglyceride in man. J. Lipid Res. 6: 119-134.
74. Guo, Z., B. Burguera, and M. D. Jensen. 2000. Kinetics of intramuscular triglyceride fatty acids in exercising humans. J. Appl. Physiol. 89: 2057-2064.